Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD
Lecture: Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines and Cure
Speaker: Ann Chahroudi, MD, PhD
Emory University, United States of America
Presented at: International Workshop on HIV & Pediatrics 2017
Learn more about the International Workshop on HIV Pediatrics 2021 that will take place from 16 July 2021 to 17 July 2021 via https://bit.ly/3hH2SRQ
The treatment of pediatric HIV infection, particularly of infants and young children, remains complex and problematic. Rapid growth and organ system maturation, as well as emotional and cognitive changes that occur across the developmental spectrum from infancy through adolescence, complicate drug development, and administration. Adherence outcomes in children have been less than robust and mental health and behavioral issues are emerging as critical to understand and address in order to ensure the success of long-term treatment. Additionally, while fewer infected children are being born, there are increasing concerns about the long-term impact of in utero and post-natal exposures to antiretroviral drugs for those children who escape HIV. Currently, an estimated 20% of all infants born in sub-Saharan Africa are exposed to HIV and antiretrovirals during pregnancy and the post-natal period.
The pediatric HIV cure agenda is an important emerging area of research. Early infant diagnosis is increasingly available globally, enabling the earlier identification of infection and provides new exciting opportunities to study acute infection in children and promising cure strategies. The HIV Pediatrics Workshop is the only meeting entirely devoted to research in the prevention and treatment of HIV infections in infants, children, and adolescents, making it the premier forum for the world’s leading researchers.
Registration for the webinar is open and fee is waived for healthcare professionals via this link https://bit.ly/3hDpMtf
For the Enduring Materials of the 2017 edition visit https://bit.ly/3bD6MaF
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Видео Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD канала Academic Medical Education
Speaker: Ann Chahroudi, MD, PhD
Emory University, United States of America
Presented at: International Workshop on HIV & Pediatrics 2017
Learn more about the International Workshop on HIV Pediatrics 2021 that will take place from 16 July 2021 to 17 July 2021 via https://bit.ly/3hH2SRQ
The treatment of pediatric HIV infection, particularly of infants and young children, remains complex and problematic. Rapid growth and organ system maturation, as well as emotional and cognitive changes that occur across the developmental spectrum from infancy through adolescence, complicate drug development, and administration. Adherence outcomes in children have been less than robust and mental health and behavioral issues are emerging as critical to understand and address in order to ensure the success of long-term treatment. Additionally, while fewer infected children are being born, there are increasing concerns about the long-term impact of in utero and post-natal exposures to antiretroviral drugs for those children who escape HIV. Currently, an estimated 20% of all infants born in sub-Saharan Africa are exposed to HIV and antiretrovirals during pregnancy and the post-natal period.
The pediatric HIV cure agenda is an important emerging area of research. Early infant diagnosis is increasingly available globally, enabling the earlier identification of infection and provides new exciting opportunities to study acute infection in children and promising cure strategies. The HIV Pediatrics Workshop is the only meeting entirely devoted to research in the prevention and treatment of HIV infections in infants, children, and adolescents, making it the premier forum for the world’s leading researchers.
Registration for the webinar is open and fee is waived for healthcare professionals via this link https://bit.ly/3hDpMtf
For the Enduring Materials of the 2017 edition visit https://bit.ly/3bD6MaF
For more medical education programs, as well as the latest scientific information, visit https://academicmedicaleducation.com/
Видео Using Infant Animal Models to Advance Pediatric HIV Prevention, Vaccines .. | Ann Chahroudi, MD, PhD канала Academic Medical Education
Показать
Комментарии отсутствуют
Информация о видео
18 марта 2021 г. 16:27:36
00:22:24
Другие видео канала
![Preview: Highlights International Workshop on HIV & Women 2021 | Sharon Walmsley, FRCPC, MD, MSC](https://i.ytimg.com/vi/R2YdYyFG4V4/default.jpg)
![A new model for early clinical development of TB drugs and its application... | Norbert Heinrich, MD](https://i.ytimg.com/vi/qFEmqKQZCwU/default.jpg)
![Clinical Considerations of Aging People Living with HIV - Marta Boffito](https://i.ytimg.com/vi/E1EWCXiQ0us/default.jpg)
![The ABC of viral hepatitis | Mark Thursz, MRCP](https://i.ytimg.com/vi/CouyxcDBHRE/default.jpg)
![Updates on WHO HIV Treatment Guidelines - Fujie Zhang, MD, PhD](https://i.ytimg.com/vi/Xyr58KfwWSc/default.jpg)
![Is HCV drug resistance an issue? | Jürgen Rockstroh, MD](https://i.ytimg.com/vi/eMJtOA164uY/default.jpg)
![Is NAFLD/NASH a Public Health Challenge in 2022? - Zobair M. Younossi, MD, MPH, FACG, FACP, AGAF](https://i.ytimg.com/vi/T-U4xYQNp_E/default.jpg)
![Antiretroviral Therapy in Pregnant Women with HIV and Neonates - Lijun Sun](https://i.ytimg.com/vi/UyvA6qjkIwU/default.jpg)
![Long Acting Antivirals for Treatment and Prevention | Martin Markowitz, MD](https://i.ytimg.com/vi/jtTBnIX504w/default.jpg)
![Exercise and aging | Wendy Kohrt, PhD](https://i.ytimg.com/vi/bkVgsTpWIr8/default.jpg)
![Symposium 1: ViiV - What’s New in HIV Treatment & Prevention for Youth? - Panel Discussion](https://i.ytimg.com/vi/FfUrMmnTJag/default.jpg)
![Invitation to join the HIV Prevention Review Meeting 2022 - 30-31 March](https://i.ytimg.com/vi/Xs4wfVPuazY/default.jpg)
![Case-Based Discussion of Oral Antivirals for COVID-19: Part 1 - Catia Marzolini, PharmD, PhD](https://i.ytimg.com/vi/AffRMzV0p_g/default.jpg)
![Anti-HBV potential of PD-1/PD-L1 blockade in chronic HBV infection | Daniel Verdon](https://i.ytimg.com/vi/kX9-cazXCVU/default.jpg)
![Research into Aging with HIV: Lessons Learned and Outstanding Challenges - Peter Reiss](https://i.ytimg.com/vi/IZ7CCP7pGE0/default.jpg)
![State of the Art Interventions in Improving Pediatric HIV Outcomes in OVC Programs - Grace Mayanja](https://i.ytimg.com/vi/B7JMeVkVOLs/default.jpg)
![Invitation by Roger Paredes, MD, PhD | European Meeting on HIV & Hepatitis 2021](https://i.ytimg.com/vi/5MEj0oMZILM/default.jpg)
![Differentiated & Simplified PrEP for HIV Prevention | Heather-Marie Schmidt, BMedSc (Hon), MPH, PhD](https://i.ytimg.com/vi/b1AmSpMLRQA/default.jpg)
![Acute hepatitis A to E, diagnosis and management | Thomas Berg, MD](https://i.ytimg.com/vi/jWQMtxvHUGg/default.jpg)
![Does resistance still matter? | Daniel Kuritzkes, MD](https://i.ytimg.com/vi/l-igc489l0E/default.jpg)